Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat

Derek A. Schreihofer, Christian Deutsch, Tara Lovekamp-Swan, Jennifer C Sullivan, Anne M. Dorrance

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

High soy (HS) diets are neuroprotective and promote vascular dilatation in the periphery. We hypothesized that an HS diet would promote vascular dilatation in the cerebrovasculature by mimicking estradiol's actions on the endothelial nitric oxide synthase (eNOS) system including increasing eNOS expression and decreasing caveolin-1 expression to increase nitric oxide (NO) production. Ovariectomized rats were fed HS or a soy-free diet (SF) ± low physiological estradiol (E2) for 4 weeks. Neither E2 nor HS altered middle cerebral artery (MCA) structure or vascular responses to acetylcholine, serotonin, or phenylephrine. Estradiol enhanced bradykinin-induced relaxation in an eNOS-dependent manner. Although E2 and HS increased eNOS mRNA expression in the brain and cerebrovasculature, they had no effect on eNOS protein expression or phosphorylation in the MCA. However, E2 decreased caveolin-1 protein in the MCA. In MCAs neither E2 nor HS altered estrogen receptor (ER) alpha expression, but E2 did reduce ER beta levels. These data suggest that HS diets have no effect on vascular NO production, and that E2 may modulate basal NO production by reducing the expression of caveolin-1, an allosteric inhibitor of NOS activity. However, the effects of E2 and HS on the cerebrovasculature are small and may not underlie their protective actions in pathological states.

Original languageEnglish (US)
Pages (from-to)236-242
Number of pages7
JournalVascular Pharmacology
Volume52
Issue number5-6
DOIs
StatePublished - May 1 2010

Fingerprint

Nitric Oxide Synthase Type III
Caveolin 1
Blood Vessels
Diet
Middle Cerebral Artery
Estradiol
Nitric Oxide
Dilatation
Caveolins
Estrogen Receptor beta
Estrogen Receptor alpha
Bradykinin
Phenylephrine
Acetylcholine
Serotonin
Phosphorylation
Messenger RNA
Brain
Proteins

Keywords

  • Estradiol
  • Estrogen
  • Middle cerebral artery
  • Vasodilatation
  • Vasoreactivity

ASJC Scopus subject areas

  • Physiology
  • Molecular Medicine
  • Pharmacology

Cite this

Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat. / Schreihofer, Derek A.; Deutsch, Christian; Lovekamp-Swan, Tara; Sullivan, Jennifer C; Dorrance, Anne M.

In: Vascular Pharmacology, Vol. 52, No. 5-6, 01.05.2010, p. 236-242.

Research output: Contribution to journalArticle

Schreihofer, Derek A. ; Deutsch, Christian ; Lovekamp-Swan, Tara ; Sullivan, Jennifer C ; Dorrance, Anne M. / Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat. In: Vascular Pharmacology. 2010 ; Vol. 52, No. 5-6. pp. 236-242.
@article{a2e631f5b6474b0caacea75685223ce0,
title = "Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat",
abstract = "High soy (HS) diets are neuroprotective and promote vascular dilatation in the periphery. We hypothesized that an HS diet would promote vascular dilatation in the cerebrovasculature by mimicking estradiol's actions on the endothelial nitric oxide synthase (eNOS) system including increasing eNOS expression and decreasing caveolin-1 expression to increase nitric oxide (NO) production. Ovariectomized rats were fed HS or a soy-free diet (SF) ± low physiological estradiol (E2) for 4 weeks. Neither E2 nor HS altered middle cerebral artery (MCA) structure or vascular responses to acetylcholine, serotonin, or phenylephrine. Estradiol enhanced bradykinin-induced relaxation in an eNOS-dependent manner. Although E2 and HS increased eNOS mRNA expression in the brain and cerebrovasculature, they had no effect on eNOS protein expression or phosphorylation in the MCA. However, E2 decreased caveolin-1 protein in the MCA. In MCAs neither E2 nor HS altered estrogen receptor (ER) alpha expression, but E2 did reduce ER beta levels. These data suggest that HS diets have no effect on vascular NO production, and that E2 may modulate basal NO production by reducing the expression of caveolin-1, an allosteric inhibitor of NOS activity. However, the effects of E2 and HS on the cerebrovasculature are small and may not underlie their protective actions in pathological states.",
keywords = "Estradiol, Estrogen, Middle cerebral artery, Vasodilatation, Vasoreactivity",
author = "Schreihofer, {Derek A.} and Christian Deutsch and Tara Lovekamp-Swan and Sullivan, {Jennifer C} and Dorrance, {Anne M.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.vph.2010.02.003",
language = "English (US)",
volume = "52",
pages = "236--242",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "5-6",

}

TY - JOUR

T1 - Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat

AU - Schreihofer, Derek A.

AU - Deutsch, Christian

AU - Lovekamp-Swan, Tara

AU - Sullivan, Jennifer C

AU - Dorrance, Anne M.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - High soy (HS) diets are neuroprotective and promote vascular dilatation in the periphery. We hypothesized that an HS diet would promote vascular dilatation in the cerebrovasculature by mimicking estradiol's actions on the endothelial nitric oxide synthase (eNOS) system including increasing eNOS expression and decreasing caveolin-1 expression to increase nitric oxide (NO) production. Ovariectomized rats were fed HS or a soy-free diet (SF) ± low physiological estradiol (E2) for 4 weeks. Neither E2 nor HS altered middle cerebral artery (MCA) structure or vascular responses to acetylcholine, serotonin, or phenylephrine. Estradiol enhanced bradykinin-induced relaxation in an eNOS-dependent manner. Although E2 and HS increased eNOS mRNA expression in the brain and cerebrovasculature, they had no effect on eNOS protein expression or phosphorylation in the MCA. However, E2 decreased caveolin-1 protein in the MCA. In MCAs neither E2 nor HS altered estrogen receptor (ER) alpha expression, but E2 did reduce ER beta levels. These data suggest that HS diets have no effect on vascular NO production, and that E2 may modulate basal NO production by reducing the expression of caveolin-1, an allosteric inhibitor of NOS activity. However, the effects of E2 and HS on the cerebrovasculature are small and may not underlie their protective actions in pathological states.

AB - High soy (HS) diets are neuroprotective and promote vascular dilatation in the periphery. We hypothesized that an HS diet would promote vascular dilatation in the cerebrovasculature by mimicking estradiol's actions on the endothelial nitric oxide synthase (eNOS) system including increasing eNOS expression and decreasing caveolin-1 expression to increase nitric oxide (NO) production. Ovariectomized rats were fed HS or a soy-free diet (SF) ± low physiological estradiol (E2) for 4 weeks. Neither E2 nor HS altered middle cerebral artery (MCA) structure or vascular responses to acetylcholine, serotonin, or phenylephrine. Estradiol enhanced bradykinin-induced relaxation in an eNOS-dependent manner. Although E2 and HS increased eNOS mRNA expression in the brain and cerebrovasculature, they had no effect on eNOS protein expression or phosphorylation in the MCA. However, E2 decreased caveolin-1 protein in the MCA. In MCAs neither E2 nor HS altered estrogen receptor (ER) alpha expression, but E2 did reduce ER beta levels. These data suggest that HS diets have no effect on vascular NO production, and that E2 may modulate basal NO production by reducing the expression of caveolin-1, an allosteric inhibitor of NOS activity. However, the effects of E2 and HS on the cerebrovasculature are small and may not underlie their protective actions in pathological states.

KW - Estradiol

KW - Estrogen

KW - Middle cerebral artery

KW - Vasodilatation

KW - Vasoreactivity

UR - http://www.scopus.com/inward/record.url?scp=77950918082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950918082&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2010.02.003

DO - 10.1016/j.vph.2010.02.003

M3 - Article

C2 - 20197113

AN - SCOPUS:77950918082

VL - 52

SP - 236

EP - 242

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 5-6

ER -